0000905148-24-001566.txt : 20240521 0000905148-24-001566.hdr.sgml : 20240521 20240521160432 ACCESSION NUMBER: 0000905148-24-001566 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240517 FILED AS OF DATE: 20240521 DATE AS OF CHANGE: 20240521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Devroe Eric CENTRAL INDEX KEY: 0001950573 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41551 FILM NUMBER: 24969291 MAIL ADDRESS: STREET 1: C/O ACRIVON THERAPEUTICS, INC. STREET 2: 480 ARSENAL WAY, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc. CENTRAL INDEX KEY: 0001781174 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825125532 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL WAY, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-207-8979 MAIL ADDRESS: STREET 1: 480 ARSENAL WAY, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 form4.xml X0508 4 2024-05-17 0001781174 Acrivon Therapeutics, Inc. ACRV 0001950573 Devroe Eric C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 true Chief Operating Officer false Common Stock 2024-05-17 4 M 0 10000 1.04 A 69097 D Stock Option (Right to Buy) 1.04 2024-05-17 4 M 0 10000 0 D 2031-01-13 Common Stock 10000 86615 D Twenty-five percent (25%) of the shares subject to the option vested on October 5, 2021, and the remaining shares subject to the option vested or shall vest in 12 equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date. /s/ Rasmus Holm-Jorgensen, Attorney-in-Fact 2024-05-21